Remote Patient Monitoring — Overdue or Overused?

Mecklai, Keizra; Smith, Nicholas L.; Stern, Ariel Dora; Kramer, Daniel B.

doi:10.1056/nejmp2033275

Cited by 54 publications

(38 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other issues such as cost effectiveness and reimbursement, choice of the method and device for the virtual visit, multidisciplinary team involvement, visit duration, and visit intervals are still to be answered for effective work planning, with special emphasis on choosing the right patients for whom telemedicine may be useful [ 28 ].…”

Section: Discussionmentioning

confidence: 99%

Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Schiller

Zornitzki

Ostrovsky

et al. 2021

IJERPH

View full text Add to dashboard Cite

Background: The COVID-19 pandemic has brought to light both challenges and unique opportunities regarding type 1 diabetes (T1D) management, including the usage of telemedicine platforms. Methods: This study was conducted in a tertiary hospital diabetes clinic. All consecutive T1D patients during March and June 2021 were asked to fill out a structured anonymous questionnaire that aimed to determine their preference regarding continuous use of a virtual platform. Results: In total, 126 T1D patients answered the questionnaire, of whom 51% were under the age of 40, half were men, half used insulin pumps, and 69% used continuous glucose monitoring. During the pandemic, the exposure of patients to virtual visits has grown about twofold, from 29% to 53%. Of the respondents, 49% expressed an interest in future usage of a virtual platform, but most of them preferred use in a hybrid manner. We found an association between preference to use telemedicine in the future and younger age, previous virtual platform experience, and confidence in being able to download data. Conclusions: Our data demonstrate that the COVID-19 experience has led to a growing interest of T1D patients in using the hybrid format of telemedicine. However, we still need to better understand who will benefit most from this platform and assess its cost-effectiveness and organization.

show abstract

Section: Discussionmentioning

confidence: 99%

Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Schiller

Zornitzki

Ostrovsky

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…Although personal digital device and PROM data are not commonly a part of routine clinical care because of a lack of EHR integration, Medicare has augmented reimbursement for remote patient monitoring, and treatment paradigms may increase use. 31 , 32 , 33 Future research analyzing larger samples and more granular personal digital device data may further elucidate meaningful associations with patient outcomes and guide clinical practice.…”

Section: Discussionmentioning

confidence: 99%

Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices

Bartlett

Ross

Shah

et al. 2021

Cardiovascular Digital Health Journal

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

“…21 Third, recent policy changes by Medicare provide reimbursement for remote patient monitoring using personal digital devices and this study will provide information about the implications of these changes. 27 28…”

Section: Discussionmentioning

confidence: 99%

Apple Watch and Withings Evaluation of Symptoms, Treatment, and Rhythm in those Undergoing Cardioversion (AWE STRUCk): A Pragmatic Randomized Controlled Trial

Dhruva

Shah

Vemulapalli

et al. 2021

Preprint

View full text Add to dashboard Cite

Introduction: Personal digital devices that provide health information, such as the Apple Watch, have developed an increasing array of cardiopulmonary tracking features which have received regulatory clearance and are directly marketed to consumers. Despite their widespread and increasing use, data about the impact of personal digital device use on patient-reported outcomes and healthcare utilization are sparse. Among a population of patients with atrial fibrillation undergoing cardioversion, our primary aim is to determine the impact of the heart rate measurement, irregular rhythm notification, and electrocardiogram features of the Apple Watch on quality of life and healthcare utilization. Methods and analysis: We are conducting a prospective, open-label multicenter pragmatic randomized clinical trial, leveraging a unique patient-centered health data sharing platform for enrollment and follow-up. A total of 150 patients undergoing cardioversion for atrial fibrillation (or atrial flutter, if they have a history of atrial fibrillation) will be randomized 1:1 to receive the Apple Watch Series 6 or Withings Move at the time of cardioversion. The primary outcome is the difference in the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) global score at six months post-cardioversion. Secondary outcomes include inpatient and outpatient healthcare utilization. Additional secondary outcomes include a comparison of the Apple Watch ECG and pulse oximeter features with gold standard data obtained in routine clinical care settings. Ethics and dissemination: The Institutional Review Boards at Yale University, Mayo Clinic, and Duke University Health System have approved the trial protocol. This trial will provide important data to policymakers, clinicians, and patients about the impact of the heart rate, irregular rhythm notification, and electrocardiogram features of widely used personal digital devices on patient quality of life and healthcare utilization. Findings will be disseminated to study participants, at professional society meetings, and in peer-reviewed journals.

show abstract

Remote Patient Monitoring — Overdue or Overused?

Cited by 54 publications

References 0 publications

Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices

Apple Watch and Withings Evaluation of Symptoms, Treatment, and Rhythm in those Undergoing Cardioversion (AWE STRUCk): A Pragmatic Randomized Controlled Trial

Contact Info

Product

Resources

About